| Name: | Mirtazapine EP Impurity F |
| Catalogue No. | VL206007 |
| CAS No. | 191546-97-1 |
| Molecular Formula | C₁₇H₁₇N₃O |
| Molecular Weight | 279.34 |
| Status | In-stock |
| IUPAC Name | 1,3,4,14b-Tetrahydro-2-methyl-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepin-10(2H)-one |
| Appearance | Yellow to Light Brown Solid |
| Description | Mirtazapine EP Impurity F (CAS No: 191546-97-1) or USP Mirtazapine Related Compound D is an impurity present in mirtazapine which is for the treatment of depression, it is a member of piperazinoazepines which are used for the treatment of major depression. It is a racemic mixture and both of its enantiomers show pharmacological activity. |
| References | Rao, Divvela V. N. Srinivasa, et al. “Synthesis of Potential Related Substances of Mirtazapine.” Arkivoc, vol. 2006, no. 15, Dec. 2006, pp. 127–32, https://doi.org/10.3998/ark.5550190.0007.f15. “Formulation Studies for Mirtazapine Orally Disintegrating Tablets.” Drug Development and Industrial Pharmacy, 2016, www.tandfonline.com/doi/abs/10.3109/03639045.2015.1104345. |
